Sandoz Expands Recall of Cefazolin Vials Over Labeling Error
Originally Published 6 months ago — by fda.gov
Sandoz has expanded a nationwide recall of one lot of Cefazolin for Injection after discovering some vials were mislabeled as Penicillin G Potassium, which could pose serious health risks if administered. No adverse events have been reported, but the company is urging healthcare providers and customers to stop using the affected product and return it.